title: NICE guidance on vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma.
authors: Kumar
authors: K
authors: Perampaladas
authors: Nicola
authors: N
authors: Hay
authors: Fiona
authors: F
authors: Rinaldi
authors: Janet
authors: J
authors: Robertson
authors: Jane
authors: J
authors: Adam
mesh_terms: D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D008545:Melanoma / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D009154:Mutation; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D048493:Proto-Oncogene Proteins B-raf / Q000037:antagonists & inhibitors / Q000235:genetics; D013449:Sulfonamides / Q000008:administration & dosage*; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf